Literature DB >> 11007523

Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma.

L Rettenbacher1, P Sungler, D Gmeiner, H Kässmann, G Galvan.   

Abstract

The aim of this study was to evaluate sentinel lymph node mapping in patients with differentiated thyroid carcinoma. Nine patients with suspected thyroid carcinoma who were scheduled to undergo thyroidectomy underwent scintigraphic localization of sentinel lymph nodes (SLNs). On the day of surgery we injected 37 MBq technetium-99m nanocolloid intratumourally. Dynamic data up to 10 min followed by planar anterior and lateral oblique images up to 1 h after tracer administration were recorded. At surgery the primary tumour was excised first, then the SLNs were removed using a gamma probe. Four patients had papillary carcinoma, two follicular carcinoma, one an oncocytic tumour and two benign tumours. An SLN was identified in all four patients with papillary carcinoma. In the two patients with follicular carcinoma, SLN detection failed. Five patients had one radioactive node, one had three and one had four. In one patient, no SLN was visible with scintigraphic imaging but at surgery three SLNs could be clearly identified using the gamma probe after removal of the primary tumour. There were no false-negative findings. This initial study indicates that in patients with papillary thyroid carcinoma detection of the SLN is possible, whereas the technique failed in two patients with follicular carcinoma. A study on a larger patient sample is now warranted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007523     DOI: 10.1007/s002590000286

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  Radioguided sentinel lymph node biopsy in patients with papillary thyroid carcinoma.

Authors:  Mattia Portinari; Paolo Carcoforo
Journal:  Gland Surg       Date:  2016-12

2.  SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement.

Authors:  Amparo Garcia-Burillo; Isabel Roca Bielsa; Oscar Gonzalez; Carles Zafon; Monica Sabate; Josep Castellvi; Xavier Serres; Carmela Iglesias; Ramon Vilallonga; Enric Caubet; Jose Manuel Fort; Jordi Mesa; Manuel Armengol; Joan Castell-Conesa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-02       Impact factor: 9.236

3.  99Tc nanocolloid sentinel node procedure in papillary thyroid carcinoma: our mono-institutional experience on a large series of patients.

Authors:  M R Pelizzo; A Toniato; N Sorgato; A Losi; F Torresan; I Merante Boschin
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

Review 4.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

5.  Sentinel lymph node biopsy in thyroid tumors: a pilot study.

Authors:  Sandro J Stoeckli; Madeleine Pfaltz; Hans Steinert; Stephan Schmid
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-03-18       Impact factor: 2.503

6.  99Tc Nanocolloid sentinel node procedure in thyroid carcinoma.

Authors:  Isabella Merante Boschin; Antonio Toniato; Andrea Piotto; Eric Casal Ide; Dario Casara; AnnaMaria Guolo; Domenico Rubello; MariaRosa Pelizzo
Journal:  Langenbecks Arch Surg       Date:  2008-07-15       Impact factor: 3.445

7.  Value of sentinel lymph node biopsy in papillary thyroid cancer: initial results of a prospective trial.

Authors:  R N Cabrera; C T Chone; D Zantut-Wittmann; P Matos; D M Ferreira; P S G Pereira; R J R Ferrari; A O Santos; A N Crespo; E C S C Etchebehere
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-03       Impact factor: 2.503

Review 8.  Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques.

Authors:  Ludovico Maria Garau; Domenico Rubello; Alice Ferretti; Giuseppe Boni; Duccio Volterrani; Gianpiero Manca
Journal:  Endocrine       Date:  2018-07-02       Impact factor: 3.633

9.  Contribution of SLN investigation with 99mTc-nanocolloid in clinical staging of thyroid cancer: technical feasibility.

Authors:  Maria Rosa Pelizzo; Domenico Rubello; Isabella Merante Boschin; Andrea Piotto; Costantino Paggetta; Antonio Toniato; Gian Luca De Salvo; Armando Giuliano; Giuliano Mariani; Dario Casara
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-18       Impact factor: 10.057

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.